Codiak BioSciences

Codiak BioSciences

Codiak Biosciences is a biotechnology company developing exosome therapeutics.

Edit ID  10271991 

Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 19 Mar 2019 6:15 pm
Edits made to:
Article (+21/-21 characters)


On January 26, 2016 Codiak BioSciences completed their series B funding round with $61 million in capital from Flagship Pioneering (lead investor), ARCH Venture Partners (lead investor), Alexandria Venture, and Alaska Permanent FundAlaska Permanent Fund.